[Atenolol in treatment of patients with airway obstruction].

[Atenolol in treatment of patients with airway obstruction].

Polski merkuriusz lekarski : organ Polskiego Towarzystwa Lekarskiego (1996-12-01)

R Chazan

ZUSAMMENFASSUNG

It is well known that beta-2-blockers are contraindicated for patients with bronchial hyperactivity. Author discusses the clinical observations in relation to treatment with atenolol in circulatory system pathology.

MATERIALIEN

Produktnummer

Marke

Produktbeschreibung

A7655

Sigma-Aldrich

Atenolol, ≥98% (TLC), powder

A-072

Supelco

Atenolol solution, 1.0 mg/mL in acetonitrile, ampule of 1 mL, certified reference material, Cerilliant^®

1044403

USP

Atenolol, United States Pharmacopeia (USP) Reference Standard

A1340000

Atenolol, European Pharmacopoeia (EP) Reference Standard